Carl Spana is the founder of Palatin Technologies. Palatin Technologies has raised $45M in total funding. Based in Cranbury, United States.
Carl Spana is the President and Chief Executive Officer of Palatin Technologies, a biopharmaceutical company focused on developing first-in-class medicines. The company specializes in creating molecules that modulate the activity of the melanocortin receptor (MCR) system, with a primary focus on advancing MC4R-based obesity programs. Palatin Technologies recently completed an $18.2 million public offering in November 2025 and an offering of $27 million in April 2006.
Full founder directory · Investor directory · Company funding database · Fundraising library